Maternal Oxygen Administration for Fetal Distress II
The Effect of Maternal Long Term High Flow Oxygen Administration During Labor on Umbilical Cord Blood Gases
1 other identifier
interventional
140
1 country
3
Brief Summary
Supplementary oxygen is routinely administered to patients, even those with adequate oxygen saturations, in the belief that it increases oxygen delivery. However, oxygen delivery depends not just on arterial oxygen content but also on perfusion. Maternal oxygen administration has been used in an attempt to lessen fetal distress by increasing the available oxygen from the mother. However, the effect of supplemental maternal oxygen therapy on fetal acid base status has been debated for more than seven decades. The investigators found the use of 2 L/min maternal oxygen during the second stage of labor did not adversely affect either the umbilical artery pH value or the fetal heart rate (FHR) pattern distribution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2021
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2018
CompletedFirst Posted
Study publicly available on registry
December 5, 2018
CompletedStudy Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedAugust 15, 2023
August 1, 2023
10 months
December 3, 2018
August 13, 2023
Conditions
Outcome Measures
Primary Outcomes (6)
Cord arterial pH values
Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.
within 30 to 60 seconds of birth
Cord arterial partial pressure of oxygen
Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.
within 30 to 60 seconds of birth
Cord arterial partial pressure of carbon dioxide
Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.
within 30 to 60 seconds of birth
Cord venous pH values
Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.
within 30 to 60 seconds of birth
Cord venous partial pressure of oxygen
Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.
within 30 to 60 seconds of birth
Cord venous partial pressure of carbon dioxide
Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.
within 30 to 60 seconds of birth
Secondary Outcomes (1)
Rate of abnormal fetal heart tracing
at 1 minute after birth
Other Outcomes (5)
Rate of cesarean delivery
at 1 minute after birth
Rate of assisted vaginal delivery
at 1 minute after birth
Apgar score less than 7
at 1 and 5 minutes after birth
- +2 more other outcomes
Study Arms (2)
air, the first and second stage of labor
NO INTERVENTIONPatients randomized to the group will receive room air. The therapy will continue until after delivery
oxygen, the first and second stage of labor
EXPERIMENTALPatients randomized to the group will receive oxygen administered by high flow facemask oxygen at 10 L/min oxygen. The therapy will continue until after delivery
Interventions
Oxygen will be administered by facemask at 10 L/min oxygen. The therapy will continue until after delivery
Eligibility Criteria
You may qualify if:
- at term (\>37 weeks, \<42 weeks), singleton, cephalic presentation, spontaneous or induced labor, normal labor, category I FHR tracings, 2 to 3 cm of cervical dilation in nulliparity, 1 to 2 cm of cervical dilation in multipara, informed consent.
You may not qualify if:
- respiratory or cardiovascular disease, diabetes mellitus or insulin-treated gestational diabetes mellitus, hypertension or preeclampsia, oligohydramnios, fetal growth restriction, placental abruption, cephalopelvic disproportion, meconium-stained amniotic fluid, tachysystole, having received O2, uterine incision (myomectomy or perforation), anemia, fever, chorioamnionitis, tobacco or alcohol use, disorders in oxygen saturations, hypotension, uncomfortable with facemask.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Department of Obstetrics and Gynecology, PLA Strategic Support Force Characteristic Medical Center
Beijing, China
Department of Obstetrics and Gynecology, Seventh Medical Center, Chinese PLA General Hospital
Beijing, China
Department of Obstetrics and Gynecology, Sixth Medical Center, Chinese PLA General Hospital
Beijing, China
Related Publications (2)
Chuai F, Dong T, Liu Y, Jiang W, Zhang L, Chen L, Chuai Y, Zhou Y. The effect of intrapartum prolonged oxygen exposure on fetal metabolic status: secondary analysis from a randomized controlled trial. Front Endocrinol (Lausanne). 2023 Jun 27;14:1204956. doi: 10.3389/fendo.2023.1204956. eCollection 2023.
PMID: 37441500BACKGROUNDChuai Y, Jiang W, Zhang L, Chuai F, Sun X, Peng K, Gao J, Dong T, Chen L, Yao Y. Effect of long-duration oxygen vs room air during labor on umbilical cord venous partial pressure of oxygen: a randomized controlled trial. Am J Obstet Gynecol. 2022 Oct;227(4):629.e1-629.e16. doi: 10.1016/j.ajog.2022.05.028. Epub 2022 May 14.
PMID: 35580635BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yunhai Chuai, Dr
Sixth Medical Center, Chinese PLA General Hospital
- PRINCIPAL INVESTIGATOR
Fang Chuai
Sixth Medical Center, Chinese PLA General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor of Obstetrics and Gynecology, Principal Investigator
Study Record Dates
First Submitted
December 3, 2018
First Posted
December 5, 2018
Study Start
January 1, 2021
Primary Completion
October 31, 2021
Study Completion
December 31, 2021
Last Updated
August 15, 2023
Record last verified: 2023-08